Over 20 Total Lots Up For Auction at One Location - TX Cleansweep 06/25

La proyección de imagen del FOE anota la aprobación del FDA para la característica micro de la dosis de la radiografía

por Lauren Dubinsky, Senior Reporter | January 27, 2015
Courtesy of EOS imaging
EOS imaging announced yesterday that the Micro Dose feature for its EOS imaging system has received FDA clearance. The company claims that it's the only pediatric radiation dose monitoring feature for X-ray systems on the market.

On January 15, The Environmental Protection Agency put out new recommendations for patients undergoing X-ray procedures. The new guidelines are meant to encourage facilities to use the "As Low As Reasonably Achievable" principle when using diagnostic and interventional X-ray systems.

Studies have shown that having children with scoliosis undergo frequent imaging to monitor their condition increases their risk of developing cancer later in life. Because of that there has been a push to monitor and manage the amount of dose administered during each procedure.

"All of the pediatric radiologists and orthopedists are very much concerned by the dose in order to protect their patients," Herve Legrand, vice president of global marketing for EOS imaging, told DOTmed News. "We are following our principle, which is the least dose you can provide to the patient, the better it is."

Studies presented at the 2013 French Society of Radiology Annual Meeting and the 2014 Annual Meeting of the Radiological Society of North America found that the Micro Dose feature produces the same dosage levels as a week of naturally-occurring background radiation in pediatric patients who undergo 2-D and 3-D follow-up exams.

Legrand said that all of their customers were eagerly awaiting clearance of the feature. Existing systems can be upgraded with the feature and the new systems will have the feature built in.

You Must Be Logged In To Post A Comment